Pleiotropy: Epidemiologic analyses and implications for return of results

dc.contributor.advisorPeters, Ulrikeen_US
dc.contributor.authorKocarnik, Jonathanen_US
dc.date.accessioned2013-07-23T18:25:48Z
dc.date.available2015-12-14T17:55:48Z
dc.date.issued2013-07-23
dc.date.submitted2013en_US
dc.descriptionThesis (Ph.D.)--University of Washington, 2013en_US
dc.description.abstractPleiotropy refers to a single gene with multiple phenotypic effects. Genetic variants associated with multiple diseases can point to shared biologic mechanisms or other similarities. The first half of this dissertation comprises two epidemiologic analyses evaluating common genetic variants for pleiotropic associations. The first investigates whether levels of the inflammatory biomarker C-reactive protein are associated with genetic variants previously associated with various inflammation-related diseases such as stroke, obesity, or type 2 diabetes. The second evaluates whether genetic variants previously associated with various cancers are also associated with melanoma. Results from both analyses provide evidence supporting both known and potentially novel pleiotropic associations. The second half of this dissertation focuses on how the presence of pleiotropy impacts the return of individual genetic results to research participants. Researchers are generating increasingly large amounts of genetic information on research participants, uncovering genetic variants with a spectrum of health implications. While many genetic variants are of little or unknown clinical significance, some genetic variants are highly predictive of disease, and can inform screening or other actions that can prevent or reduce disease. A few variants are sufficiently important to suggest an ethical duty on the part of the researcher to return that genetic information to a participant. Conversely, other variants may impart information on risk that is not actionable, and returning such information may inflict more harms than benefits. Recent guidelines have proposed various criteria for prioritizing which results are appropriate or not appropriate for return, focusing on weighing the clinical validity and clinical utility of a particular genetic result. However, these guidelines do not currently take into account that genetic variants may have multiple meanings, which might have contradicting recommendations for whether that same variant should be returned. This dissertation reviews the concept and extent of pleiotropy, reviews current recommendations for returning results, and explores the ways in which the existence of pleiotropic variants impacts these guidelines. This dissertation proposes a potential framework for considering pleiotropic relationships in return recommendations, and suggests that future guidelines will need to account for pleiotropy if they are to be effective.en_US
dc.embargo.termsDelay release for 2 years -- then make Open Accessen_US
dc.format.mimetypeapplication/pdfen_US
dc.identifier.otherKocarnik_washington_0250E_11517.pdfen_US
dc.identifier.urihttp://hdl.handle.net/1773/22764
dc.language.isoen_USen_US
dc.rightsCopyright is held by the individual authors.en_US
dc.subjectEthical Legal Social Implications; Genetic epidemiology; Incidental findings; Pleiotropy; Public Health Genetics; Return of resultsen_US
dc.subject.otherPublic healthen_US
dc.subject.otherGeneticsen_US
dc.subject.otherEpidemiologyen_US
dc.subject.otherpublic health geneticsen_US
dc.titlePleiotropy: Epidemiologic analyses and implications for return of resultsen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Kocarnik_washington_0250E_11517.pdf
Size:
1.82 MB
Format:
Adobe Portable Document Format